Search Press releases

Press releases teaser image
3 May 2026

UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-cell engagers

Read More
Press releases teaser image
1 May 2026

UCB announces acquisition of IMIDomics’ Patient Insight Business, strengthening capabilities in immune-mediated inflammatory diseases (IMIDs)

Read More
Press releases teaser image
30 Apr 2026

UCB’s General Meeting of Shareholders 2026

Read More
Press releases teaser image
24 Apr 2026

Acquisition of own shares

Read More
Press releases teaser image
17 Apr 2026

Acquisition of own shares

Read More
Press releases teaser image
17 Apr 2026

UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe